Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125468462 | 12546846 | 2 | F | 2006 | 20160816 | 20160711 | 20160826 | EXP | US-ELI_LILLY_AND_COMPANY-US201607000323 | ELI LILLY AND CO | 0.00 | F | Y | 89.80000 | KG | 20160825 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125468462 | 12546846 | 1 | PS | HUMULIN 70/30 | INSULIN HUMAN | 1 | Unknown | 35 U, BID | U | U | 18780 | 35 | IU | INJECTION | BID | ||||
125468462 | 12546846 | 2 | SS | HUMULIN 70/30 | INSULIN HUMAN | 1 | Unknown | 35 U, BID | U | U | C526913E | 18780 | 35 | IU | INJECTION | BID | |||
125468462 | 12546846 | 3 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | UNK, UNKNOWN | Y | 0 | INJECTION | ||||||||
125468462 | 12546846 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
125468462 | 12546846 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
125468462 | 12546846 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
125468462 | 12546846 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
125468462 | 12546846 | 8 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
125468462 | 12546846 | 9 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | U | 0 | |||||||||||
125468462 | 12546846 | 10 | C | POTASSIUM | POTASSIUM | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
125468462 | 12546846 | 11 | C | FISH OIL | FISH OIL | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
125468462 | 12546846 | 12 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125468462 | 12546846 | 1 | Type 2 diabetes mellitus |
125468462 | 12546846 | 3 | Type 2 diabetes mellitus |
125468462 | 12546846 | 8 | Hypersensitivity |
125468462 | 12546846 | 9 | Asthma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125468462 | 12546846 | OT |
125468462 | 12546846 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125468462 | 12546846 | Alopecia | |
125468462 | 12546846 | Asthenia | |
125468462 | 12546846 | Blood glucose abnormal | |
125468462 | 12546846 | Candida infection | |
125468462 | 12546846 | Cardiac failure congestive | |
125468462 | 12546846 | Diabetic amyotrophy | |
125468462 | 12546846 | Diabetic neuropathy | |
125468462 | 12546846 | Dysphagia | |
125468462 | 12546846 | Fall | |
125468462 | 12546846 | Fat embolism | |
125468462 | 12546846 | Feeding disorder | |
125468462 | 12546846 | Fungal infection | |
125468462 | 12546846 | Gait disturbance | |
125468462 | 12546846 | Hunger | |
125468462 | 12546846 | Myositis | |
125468462 | 12546846 | Nodule | |
125468462 | 12546846 | Nosocomial infection | |
125468462 | 12546846 | Pain | |
125468462 | 12546846 | Skin infection | |
125468462 | 12546846 | Visual acuity reduced | |
125468462 | 12546846 | Weight decreased | |
125468462 | 12546846 | Weight increased | |
125468462 | 12546846 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125468462 | 12546846 | 1 | 2006 | 201509 | 0 | |
125468462 | 12546846 | 2 | 2006 | 0 | ||
125468462 | 12546846 | 3 | 201509 | 0 |